Autor: "Paragas EM" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Epigenetics in drug disposition & drug therapy: symposium report of the 24 North American meeting of the International Society for the Study of Xenobiotics (ISSX).
Autorzy:: Maldonato BJ; Department of Nonclinical Development and Clinical Pharmacology, Revolution Medicines, Inc, Redwood City, CA, United States.
Vergara AG; Department of ADME & Discovery Toxicology, Merck & Co., Inc, Rahway, NJ, United States.
Yadav J; Department of ADME & Discovery Toxicology, Merck & Co., Inc, Rahway, NJ, United States.
Glass SM; Janssen Research & Development, San Diego, CA, United States.
Paragas EM; Amgen Inc, South San Francisco, CA, United States.
Li D; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR, United States.
Lazarus P; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, United States.
McClay JL; Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, United States.
Ning B; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR, United States.
Daly AK; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Russell LE; Drug Metabolism and Pharmacokinetics, AbbVie Inc, North Chicago, Illinois, United States.; Pokaż więcej
Źródło:: Drug metabolism reviews [Drug Metab Rev] 2022 Aug; Vol. 54 (3), pp. 318-330. Date of Electronic Publication: 2022 Aug 24.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Drug Discovery*
Epigenesis, Genetic*
MicroRNAs*/genetics
RNA, Long Noncoding*/genetics
DNA Methylation ; Humans ; North America

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Paragas EM"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Język